CLOs on the Move

Mannatech

www.mannatech.com

 
Mannatech, Incorporated is a global wellness solution provider. The Company develops and sells a range of nutritional supplements, topical and skin care products, and weight-management products that target optimal health and wellness.
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

QuadraMed

Quadramed is an Electronic Document Management solution for your healthcare network that acts as a repository for downloaded and scanned documents.

International Medical Equipment

International Medical Equipment, Inc. is a San Marcos, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

memorial Clinic

memorial Clinic is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mason City Clinic

The Mason City Clinic was formed on January 1, 1989, with the merger of three physician groups -- Surgical Associates, Internal Medicine Associates and Independent Medical Surgical Group.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.